Previous Close | 0.1200 |
Open | 0.1200 |
Bid | 0.0100 |
Ask | 0.2800 |
Strike | 123.00 |
Expire Date | 2024-06-14 |
Day's Range | 0.1200 - 0.1200 |
Contract Range | N/A |
Volume | |
Open Interest | 126 |
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
(Updated - June 10, 2024 11:28 AM EDT)